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ABSTRACT
Wnt-5a is a non-transforming Wnt protein. Since
Wnt-5a mRNA and protein levels differ within
and between tumours, the potential of Wnt-5a as a
prognostic factor has been debated. We have
previously shown that the lack of Wnt-5a protein is
a predictor of shorter disease-free survival in human
breast cancer. Recently, however, we also showed
that the breast tumours lacking Wnt-5a protein had
a high or normal level of Wnt-5a mRNA that
might explain the discrepancies in previous studies.
We here report that Wnt-5a is regulated at the post-
transcriptional level. The regulation was mediated
by the Embryonic Lethal Abnormal Vision (ELAV)-
like protein HuR, which inhibited translation of
Wnt-5a when bound to highly conserved AU-rich
sequences in the 30-untranslated region (30-UTR)
of the Wnt-5a mRNA molecule, as shown by both
HA-tagged Wnt-5a- and Luciferase-Wnt-5a-30-UTR
reporter assays. The HuR-dependent inhibition of
Wnt-5a was supported by the fact that active HuR
is located in the cytoplasm in invasive human
breast tumours and that hypoxia-induced activation
of HuR inhibits translation of both Luciferase-Wnt-
5a-30-UTR and endogenous Wnt-5a protein. We
propose that the lack of Wnt-5a protein expression
in invasive human breast tumours is caused by a
HuR-mediated suppression of Wnt-5a mRNA
translation.
INTRODUCTION
Wnt proteins inﬂuence multiple developmental processes and
have also been implicated in carcinogenesis, including the
development of breast cancer (1–4). Depending on which
signalling pathway the Wnt proteins activate, they are
referred to as canonical (Wnt/b-catenin) or non-canonical
Wnt proteins [reviewed in (5)]. Wnt-5a has been character-
ized as a non-canonical (5–10) and non-transforming Wnt
protein (11) that is important for cellular adhesion, migration,
planar cell polarity and convergent extension movements.
We have previously shown that expression of Wnt-5a is a
predictor of longer disease-free survival in human breast can-
cer (12,13). Expression of Wnt-5a in mammary cells confers
a more differentiated phenotype (14), an increased adhesion
and a decreased motility (15,16). Recent evidence links
both canonical (Wnt/b-catenin) and non-canonical (Wnt/
Ca2+) pathways to tumour invasion and metastasis (17).
However, the importance for Wnt-5a signalling in metastatic
processes is debated and conﬂicting results concerning the
expression levels of Wnt-5a in different invasive tumours
can be found in the literature (9,12,18–24). There are proba-
bly two reasons for this; ﬁrst, an abnormal protein expression
level of Wnt-5a can affect adhesion and metastasis both
when being over-expressed (loosely attached cells; malignant
melanoma) and repressed (ﬁrmly attached cells; breast
cancer). Thus, loosely attached cells will display an increased
capacity to migrate upon increased adhesion (Wnt-5a signal-
ling) while ﬁrmly attached cells will increase their migration
upon a decreased adhesion (lack of Wnt-5a signalling).
Second, most early studies concerning the role of Wnt-5a
in cancers have analysed the expression levels of Wnt-5a
mRNA and not protein. In a recent study, we show that
breast tumours lacking Wnt-5a protein expression have a
high or normal level of Wnt-5a mRNA as judged by in situ
hybridization (13). This means that studies concerning
Wnt-5a expression can only be judged by protein analysis
of Wnt-5a. It also indicates that Wnt-5a expression probably
is regulated at the post-transcriptional level.
Post-transcriptional regulation can be achieved by different
means and includes mRNA processing, nucleo-cytoplasmic
export, mRNA localization, mRNA stabilization and transla-
tional regulation [reviewed in (25,26)]. These processes are
inﬂuenced by the conserved sequence elements located in
the untranslated regions (UTRs) of the mRNA molecules
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and affect its properties [reviewed in (26,27)]. Proteins bind
to UTRs via speciﬁc RNA-recognition motifs (RRM) and
the mRNA binding sites are usually located in the 30 ends
of mRNAs. The sites are most often AU-rich or U-rich
sequences and the binding proteins are therefore referred
to as AU-rich element binding proteins (ARE-binding
proteins). ARE-binding proteins can stabilize (AUBF,
Elav-like family) or destabilize (AUF1, TTP and KSRP)
mRNAs (25–28). One common cellular mechanism is thus
to produce unstable mRNAs that can be stabilized upon
binding of speciﬁc RNA-binding proteins (27). This way,
the output of mRNAs for a speciﬁc gene can be constant,
but will yield high levels of protein only when the mRNAs
are stabilized and subsequently translated. Another less
well-described mechanism is to suppress translation (TIAR,
TIA-1 and CUGBP2) (25,29,30).
The Elav-like family of ARE-binding proteins include the
proteins HuR, HuD, HuC and Hel-N1 (27,31). They are most
well known as mRNA stabilizing proteins that bind AREs in
the 30-untranslated regions (30-UTRs) of unstable mRNAs.
They act as nuclear-cytoplasmic shuttle proteins that pre-
dominantly are expressed in the nucleus but shuttle out into
the cytoplasm upon initiation of cell signalling [e.g. by p38
MAPK, Wnt/b-catenin and Notch signalling; reviewed in
(26)] or under stress conditions, such as hypoxia (26,32).
Recent studies reported that cytoplasmic localization of
HuR is associated with a high tumour grade or invasiveness
in ovarian and breast cancers (33–36). These data are parti-
cularly interesting in relation to the observed shorter disease-
free survival in breast cancer patients with reduced Wnt-5a
protein expression (12,13). In this study we investigated
why the protein- but not mRNA levels of the prognostic mar-
ker Wnt-5a, are decreased in invasive ductal breast cancer.
MATERIALS AND METHODS
Constructs
The cDNA3 vector was obtained from Invitrogen and the
pGL3-Luciferase and cytomegalovirus (CMV)–Renilla
vectors from Promega. The 30-UTR parts corresponding to
Wnt-5a 30-UTR 1462–1528 (1–66 bp), 1462–1645
(1–183 bp) and 1462–1720 (1–258 bp) were PCR-ampliﬁed
from cDNA kindly provided by Prof. A. Harris, using primers
with 50 XbaI sites in the sense primer (50-tctagagtagtgggtgcc-
acccagcactcagccc-30) and antisense primers [50-gcttatttatagaa-
agtacagtgattctg-30 (1–66), 50-ggtttattattaatattataattattatttggc-30
(1–183) and 50-ggatctttgaaaaggtaatacaagacttcttt-30 (1–258)].
The puriﬁed fragments were digested with XbaI and the
pcDNA3 vector with XbaI/ApaI (ApaI site blunt-ended).
The constructs were sequenced and subsequently digested
with EcoRI/EcoRV (Wnt-5a), HindIII/XbaI (constructs desig-
nated L1 and L3) and KpnI/XbaI (constructs designated L
and L2) and ligated to Wnt-5a (EcoRI/EcoRV; pcDNA3-
HA-Wnt-5a) a kind gift from Dr M. Sen, or Luciferase
(HindIII/XbaI or KpnI/XbaI; pGL3).
Cells and culture conditions
The HB2, non-cancerous mammary epithelial cell line, is
a subclone of the MTSV-7 cell line originating from the
laboratory of Dr J. Taylor-Papadimitriou (ICRF, UK) (27).
The human breast cancer cell lines MCF-7 and T47D were
purchased from ATCC. The HB2 cells were cultured
in DMEM supplemented with 10% fetal bovine serum,
10 mg/ml bovine insulin and 5 mg/ml hydrocortisone. The
other cell lines were cultured in DMEM supplemented with
10% fetal bovine serum. All cell cultures were kept at 37 C
in a humidiﬁed atmosphere with 5% carbon dioxide.
Western blotting
Adherent cells grown to subconﬂuency on tissue culture
plates were washed with phosphate-buffered saline (PBS)
and lysed in 250 mlo f5 · concentrated Laemmli buffer
supplemented with 100 mM DTT. The samples were boiled
for 30 min and then subjected to electrophoresis on 10%
SDS–polyacrylamide separating gel. The separated proteins
were electrotransferred to PVDF membranes, which were
incubated with 5% non-fat milk or PBS supplemented with
0.05% Tween (PBS-T) for 1 h at room temperature. There-
after, the membranes were probed with antibodies against
Wnt-5a produced in our lab as described previously (12)
(1:2000), anti-HuR [Santa Cruz (1:1000)] or anti-HA
[Molecular probes (1:5000)], respectively, for 1 h at room
temperature. The separated protein bands were visualized
by incubating the membranes with horseradish peroxidase
(HRP)-conjugated secondary antibodies and ECL. The blots
were re-probed with an antibody against b-actin to ascertain
equal protein loading.
RNA electrophoretic mobility shift assay (REMSA) and
ultraviolet (UV)-crosslinking
32P-labelled cRNAs corresponding to the coding region
HA-Wnt-5a (ctrl), 1–66 30-UTR (#1), 1–183 30-UTR (#2) or
1–258 30-UTR (#3) were produced using puriﬁed PCR-
ampliﬁed cDNA spanning the T7 site in the pcDNA3 vector
(50-cccactgcttactggcttatcg) and antisense primers for each
insert (coding region; c.r. 50-ggaccagtttgtgtgcaagtag) and
T7 polymerase (Promega) according to the manufacturer’s
procedure. The mutated probe was produced in the same
way but using primers corresponding to the sense primer
spanning the T7 site in the pcDNA3 vector (50-cccactgcttactg-
gcttatcg) and an antisense primer (50-taatatgataatgatgatgtggc-
aataatgggggtgggaaccacgaaaaatatgtattttgtggatctttgaaaaggtaata-
caagacttctttgggccc) and Digoxigenin labelled rUTPs (Roche).
For UV-crosslink immunoprecipitation experiments the
probes were also labelled with Digoxigenin (Roche). All
regents for cDNA production were purchased from Promega,
except for
32P-UTP (Amersham). Probes were DNAse treated
(Invitrogen), phenol extracted and dissolved in Munro’s buf-
fer [10 mM HEPES (pH 7.6), 3 mM MgCl2, 40–100 mM
KCl, 5% Glycerol, 1 mM DTT]. The cold probe was prepared
using rUTP (Promega) instead of radiolabelled-UTP.
Nuclear and cytoplasmic extracts were prepared as described
previously (37), and diluted in Munro’s buffer (1:5). Each
probe (50000 c.p.m.) was incubated with 18 ml of the extracts
for 30 min at room temperature. Subsequently, RNAse T1
(1 U; Promega) and Heparin (5 mg/ml) was added for
5 min each, the samples were diluted in RNA native loading
buffer [30 mM Tris–Hcl (pH 7.5), 40% Sucrose and 0.2%
BFB] and subjected to native PAGE gel (4%) electrophoresis.
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intensifying screens at  70 C. For cold competition, the
cold probe was added in 10-fold excess for 10 min prior to
addition of the radiolabelled probe. In the supershift
experiments, the antibody was added after 15 min of incu-
bation. UV-crosslinking was performed as described above
and further subjected to UV-crosslinking in a Stratalinker
(250 mJ/m
2) and subsequently analysed using SDS–PAGE
(10%) analysis and normal Laemmli-DTT loading buffer.
Immunoprecipitation of UV-crosslinked products were per-
formed using normal lysis buffer [100 mM Tris–HCl
(pH 7.5), 1% NP-40, 5 mM EDTA, 5 mM EGTA, 50 mM
NaCl, 2 mM Na3VO4,2 0mg/ml aprotinin, 1 mg/ml leupeptin,
2.5 mM benzamidine and 2 mM Pefabloc
R (Roche)] and a
control IgG1 antibody or anti-HuR antibodies (Santa Cruz)
together with RNAse-inhibitor treated Protein A-Sepharose
beads (Amersham) for 1 h. The beads were washed ﬁve
times in ice-cold wash buffer [50 mM HEPES (pH 7.4),
1% Triton X-100, 0.1% SDS, 150 mM NaCl and 2 mM
Na3VO4) and were boiled immediately in Laemmli buffer
with DTT. For experiments using Digoxigenin labelled
probes a DIG luminescent detection kit for nucleic acids
(Roche) was used.
Transient transfections and luciferase assays
HB2 cells were transfected with Oligofectamine reagent
(Invitrogen) according to the manufacturer’s instructions.
Transfections were performed using 1 · 10
6 cells, 2 mg
of HA-Wnt-5a-30-UTR constructs and 0.1 mg of CMV–
controlled Renilla reporter gene per transfection, or 0.2 mg
of Luciferase-30-UTR reporter gene construct and 0.1 mgo f
CMV–controlled Renilla reporter gene. For HuR transfec-
tions, 1 mg of cDNA3 (empty vector), 1 mg HuR plasmid
or 1 mg mutated HuR (M1) plasmid, kindly provided by
Prof. J. Steitz, was used. Preparation of protein extracts and
luciferase assays were performed with a Dual-Luciferase
Reporter Assay System (Promega). The luciferase activity
obtained was normalized against the activity of the cotrans-
fected CMV–Renilla reporter gene. In the expression experi-
ments using HB2 cell lysates from cells transfected with
different HA-Wnt-5a-30-UTR constructs, an equal amount
of each lysate was analysed for Renilla activity to control
for transfection efﬁciency and protein concentration. For
hypoxic conditions, the cells were plated in two 24-well
plates for each experiment and transfected as described
above, with the exception that the transfections were
supplemented with serum. The cells were cultured for a
total of 24 h under hypoxic (1% O2) conditions, in a Hypoxia
Workstation 400 (Ruskinn Technology, Leeds, UK) con-
nected to a Ruskinn gas mixer module, or normoxic (20%
O2) conditions.
RNA turnover
HB2 cells were transfected with Luciferase-30-UTR cons-
tructs, Renilla and where indicated with cDNA3, HuR or
M1 HuR as described above. Actinomycin D (10 mg/ml;
Sigma–Aldrich) was added to the cells 3 h prior to harvesting.
RNA was prepared using Trizol (Invitrogen) and OD mea-
surements were performed to assure equal loading. Northern
blot hybridization was performed using
32P-labelled SP6
probes generated from the HA-Wnt-5a or Luc constructs or
with a
32P-labelled oligo speciﬁc for Renilla.
In vitro translation and transcription
In vitro translation was performed using the programmed
T7/SP6 rabbit reticulocyte lysate system (Promega) and
addition of 0.1 mg of the Luciferase-30-UTR construct and
Renilla plasmid together with 1 mg cDNA3, HuR or M1
HuR, all according to the manufacturers procedures. The
luciferase activity was measured using 1:10 of the reactions.
For in vitro transcription rate analysis, [
32P]UTP was added
to the reactions programmed with 0.1 mg of the Luciferase-
30-UTR constructs only and after 15 min the mRNA was pre-
cipitated with 10% ice-cold TCA, incubated on ice for
10 min, washed once in ice-cold 10% TCA and three times
in ice-cold 95% ethanol. The amount (c.p.m.) of incorporated
UTP was measured using a b-counter. Unprogrammed reticu-
locyte lysate containing the equal amount of [
32P]-UTP was
used as a control. The results were corrected for the percent-
age of UTPs in each construct. For in vitro translation experi-
ments using the Transcend  non-radioactive translation
detection system (Promega), 0.5 mg of the Luciferase-30-
UTR constructs (L, L1, L2, L3) were used in 20 ml reactions
and of these 1 ml were used for SDS–PAGE analysis. For
in vitro translation experiments, using HuR pre-programmed
rabbit reticulocyte lysates 1 mg of HuR cDNA was added and
translated in a 50 ml reaction. Of this reaction 1 ml was added
to the 20 ml Luciferase-30-UTR reactions.
Immunofluorescence
The cells were seeded on glass coverslips and grown over-
night to allow them to adhere. Thereafter, the cells were
washed with PBS, ﬁxed in methanol for 10 min and blocked
in 3% BSA–PBS for 1 h at RT. Cells were stained with anti-
HuR from Santa Cruz (1:500) or isotype control antibodies in
1% BSA–PBS for 1 h at RT, after which the cells were
washed ﬁve times with PBS and then incubated with sec-
ondary anti-rabbit Alexa Flour 488 (1:500) antibodies. There-
after, the coverslips were washed ﬁve times in PBS, mounted
in ﬂuorescent mounting medium (DAKO), and examined and
photographed in a Nikon Eclipse 800 microscope, using a
60· objective. Images were recorded with a scientiﬁc-
grade, charge-coupled device (CCD) camera (Hamamatsu)
and were analysed with HazeBuster deconvolution software
(VayTek).
RESULTS
The 30-UTR of Wnt-5a is evolutionarily conserved and
contains AU-rich stretches
The human Wnt-5a 30-UTR, as shown in Figure 1A is
 2.5-fold longer than the coding region and more than ﬁve
times the length of the 50-UTR (38,39). To ﬁnd possible
important RNA–protein-binding sites (AREs) we searched
for evolutionarily conserved sequence elements in the
50-UTR and the 30-UTR of the Wnt-5a mRNA. The sequence
corresponding to 143–318 bp in the 50-UTR was conserved
between dog, mouse, rat and human, but no AREs were
found (data not shown). However, the 30-UTR contained
3990 Nucleic Acids Research, 2006, Vol. 34, No. 14sequences that were conserved between chinchilla, mouse, rat
and human (shaded in Figure 1B) and many of these har-
boured putative AREs of class III or class I according to
the deﬁnition of AREs [reviewed in (25,40); Figure 1C]. In
Figure 1B and C the 30-UTR is renumbered (1–2570 bp)
for simplicity. The most conserved region is located 133–
192 bp 30 of the STOP-codon. We further analysed the pre-
dicted 2D mRNA folding structure (41,42) (http://www.
bioinfo.rpi.edu/~zukerm/) and the most conserved regions
of AU-rich stretches formed hair-pin and loop structures
that were preserved (data not shown) indicating that these
sequences are AREs with a high probability of binding
RNA-binding proteins (43).
Wnt-5a translation is governed by the 30-UTR
The Wnt-5a mRNA has previously been reported to occur as
at least two transcripts (7 and 4 kb) via utilization of two
polyadenylation signals located at  4.4 and 6.8 kb (38,39).
To our knowledge however, only the ﬁrst 4 kb have been
sequenced and the role for the 7 kb transcript is at present
unknown. Wnt-5a is expressed at low levels in normal
human breast epithelial cells (24). As shown in Figure 1D,
the non-cancerous human breast epithelial cell line, HB2,
primarily produces the 4 kb transcript. To analyse whether
the conserved structures in the 30-UTR were capable of regu-
lating Wnt-5a protein expression at the post-transcriptional
Figure 1. (A) A schematic drawing of the full-lengths human Wnt-5a mRNA (accession no. NM_003392). (B) Evolutionary conserved regions of the 30-UTR
are indicated by dark shadings. Numbers indicate approximate nucleotides after STOP-codon. (C) mRNA sequence of Wnt-5a 30-UTR from STOP-codon
(1–258 bp). W1 and L1 represents construct (1–66 bp), W2 and L2 construct (1–183 bp) and W3 and L3 constructs (1–258 bp). (D) The Wnt-5a mRNA molecule
is shown by northern blot analysis of mRNA from HB2 cells. Both a 4 kB and a 7 kB band are visualized as has been described previously (39) although, the 4 kB
transcript is primarily expressed in HB2 cells.
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30-UTR. The cloned 30-UTR stretches were either placed
down-stream of the HA-tagged Wnt-5a cDNA or the reporter
gene Luciferase. Both the Wnt-5a (W in Figure 2A) and
the Luciferase (L) gene were driven by the pCMV promoter
and contained the bovine growth hormone polyadenylation
signal [BGH poly(A)] in order to obtain a basic and unre-
gulated level of translation (Figure 2A). The different
constructs were, as described in Figure 2A, controls devoid
of the 30-UTR (W and L), 1–66 bp of the 30-UTR (W1 and
L1), 1–183 bp with the most conserved ARE (W2 and L2)
and ﬁnally 1–258 bp (W3 and L3).
To analyse whether the AREs regulated Wnt-5a protein
expression, we transfected HB2 cells with the different
HA-Wnt-5a containing vectors and analysed the protein
expression levels by western blot using an anti-HA antibody.
As shown in Figure 2B the protein levels of transfected
Wnt-5a decreased with increasing length of the 30-UTR.
The effect on protein expression was gene independent
since the same results were obtained using the Luciferase
expression plasmid series, cotransfected with a CMV-
controlled Renilla expression plasmid (Figure 2C). The
experiments were performed as several separate experiments
(n ¼ 12), using different preparations of the L-L3 cDNA, and
the Renilla expression plasmid was always mixed in the stock
solution that subsequently was used to dilute the Luciferase
plasmids (L, L1, L2 and L3) to assure an equal basal Renilla
expression level.
To investigate whether the conserved AREs in the 30-UTR
were destabilizing motifs, a series of mRNA stability experi-
ments with Actinomycin D were performed. The half-life of
endogenous Wnt-5a upon Actinomycin D treatment was  3h
(data not shown). Importantly, the addition of the 30-UTR
regulatory domains to the Luciferase gene did not affect the
stability of the mRNAs as shown by similar transfection
experiments described above, and subsequent northern
blotting using Luciferase and Renilla speciﬁc probes
(Figure 2D). Indeed, treatment with Actinomycin D for 3 h
did not lead to a decreased amount of mRNA indicating
that the regulatory domains in the ﬁrst 1–258 bp of the
30-UTR were neither mRNA destabilizing motifs, nor stabi-
lizing motifs. Therefore the data suggested that the evolution-
arily conserved elements could suppress translation of the
Wnt-5a gene.
HuR is one important protein that binds the
Wnt-5a 30-UTR AREs
To further characterize possible mRNA binding proteins that
can bind the AREs in the Wnt-5a 30-UTR we performed a
UV-crosslinking experiment with radiolabelled mRNAs
corresponding to the coding region of Wnt-5a as control
(ctrl) or the different 30-UTR fragments (1: 1–66, 2: 1–183,
3: 1–258 bp) together with cytoplasmic or nuclear extracts
of HB2 cells. The reactions were subjected to a 10% SDS–
PAGE and analysed by autoradiography. As shown in
Figure 3A (left), there were at least four different proteins
binding to the mRNAs. One protein of 20 kDa bound within
the ﬁrst 1–66 bp, one at 36 kDa within 66–183 bp and two
(98 kDa and 45 kDa) showed enhanced binding with increa-
sing length of the 30-UTR. As a control, a UV-crosslink
experiment using probe 3 alone (3 w/o prot), or a mutated
probe 3 (D3) together with nuclear lysates from HB2
cells, was performed (Figure 3A, right). As can be seen, the
mutated probe 3 showed a decreased binding to the pro-
teins corresponding to 36 and 98 kDa whereas probe 3
alone (3 w/o prot) did not give rise to background bands.
HuR has a molecular weight of 36 kDa and is known to
bind AREs of all classes (31). In fact, HuR is one ARE-
binding protein that was previously reported to be affected
in breast cancer (33–36).
To determine the ability of HuR to bind to the Wnt-5a
30-UTR, REMSAs (Figure 3B and C) were performed with
the control probe (ctrl) or the different 30-UTR probes.
When cytoplasmic and nuclear protein extracts were analysed
a band appeared with the 30-UTR probes 2 and 3 (1–183
and 1–258 bp). This correlated with the UV-crosslink data
(Figure 3A). To analyse whether this band contained HuR,
we performed supershifts (Figure 3C) with a HuR speciﬁc
antibody together with probe 3 (1–258 bp; left) or a control
IgG (right). Addition of the HuR speciﬁc antibody led to
the disappearance of the faster migrating band, with a shift
seen as a darker shade at the slower migrating bands. A
cold probe (C) corresponding to probe 3 (1–258 bp)
competed for binding (Figure 3C) and probe 3 alone (3 w/o
prot) did not give any background bands.
To assure that HuR indeed bound to the Wnt-5a 30-UTR we
performed a UV-crosslink immunoprecipitation assay
(Figure 3D). In contrast to immunoprecipitation with the
speciﬁc anti-HuR antibody, the control IgG1 neither pulled
down HuR nor the digoxigenin labelled probe 3 (left).
HuR suppresses Wnt-5a translation in vivo
We next wanted to investigate a possible role for HuR regar-
ding Wnt-5a translation in vivo and therefore transfected the
human breast epithelial cell line, HB2, with an expression
vector coding for wild-type (wt) HuR or a mutated HuR
(M1), which is unable to bind mRNA (44), together with
the different Luciferase-30-UTR clones (Figure 4A). Indeed,
the over-expressed wt HuR protein affected the L2 and L3
expression levels signiﬁcantly as compared to the vectors
that do not bind HuR (L and L1). In contrast, the mutated
HuR plasmid M1, that cannot bind mRNAs, did not signiﬁ-
cantly affect any of the Luciferase-expression plasmids.
Moreover, the Luciferase-30-UTR mRNA levels remained
constant even in the presence of over-expressed HuR, irre-
spectively of Actinomycin D treatment as indicated by north-
ern blots (Figure 4B). Thus, this clearly suggests that HuR did
not affect Wnt-5a mRNA stability when bound to the AREs
of L2, but rather regulates the translation efﬁciency. The
transcription rate of Luciferase in vitro was unaffected by
addition of the 30-UTR elements with exception for the L2
construct (discussed in detail below), as measured by incor-
porated [
32P]rUTP where the number of UTPs were corrected
for (Figure 4C). The translation efﬁciency was also measured
in a cell free system using Rabbit reticulocyte lysates together
with the Transcend  non-radioactive translation detection
system. The protein content of the rabbit reticulocyte lysate
system is to our knowledge not fully known. However, one
can expect that the in vitro translation system differ from
the cellular context regarding the function of various
3992 Nucleic Acids Research, 2006, Vol. 34, No. 14Figure 2. (A) Schematic drawing of the eight constructs produced with HA-Wnt-5a (W) followed by 1–66 bp (W1), 1–183 bp (W2) and 1–258 bp (W3) of the
Wnt-5a 30-UTR; or Luciferase (L, L1, L2 and L3). (B) Western blot of transfected (W, W1, W2 and W3) HB2 human mammary epithelial cells revealed with
anti-HA antibody to avoid endogenous Wnt-5a detection. The lower panel shows a histogram (mean ± SD) representing a ratio between OD measurements of
HA-tag/OD endogenous Wnt-5a levels. (C) Luciferase assay of transfected (18–20 h) (L, L1, L2 and L3) HB2 human mammary epithelial cells cotransfected
with Renilla. Relative Luciferase Units (RLU)/RLU (transfection efficiency control) indicate decreased expression of Luciferase reporters containing 30-UTRs.
Error bars indicate SEM (n ¼ 12). (D) Transfections in (C) were treated with Actinomycin D for 3 h and subjected to northern blot with Luciferase and Renilla
specific probes. The lower panel shows a histogram (mean ± SD) representing the ratio between OD Luciferase / OD Renilla. One out of four experiments is
shown. Statistical analyses were performed using Student’s paired t-test (***P < 0.001).
Nucleic Acids Research, 2006, Vol. 34, No. 14 3993mRNA binding proteins. We therefore performed one set of
experiments using rabbit reticulocyte lysate only (Figure 4D
upper panel) and one using HuR pre-programmed reticulo-
cyte lysate (lower panel). We did not detect any signiﬁcant
difference regarding the in vitro translation efﬁciency
between the Luciferase-30-UTR constructs when using
only reticulocyte lysate (upper panel) whereas translation of
L3 was signiﬁcantly inhibited when adding HuR pre-
programmed reticulocyte lysate (lower panel). The fact that
the L2 construct showed an increased transcription rate
(Figure 4C), and that the L2 construct was less reduced
than L3 in the previous transfection experiment
Figure 3. (A) UV-crosslinking experiments of radiolabelled probes corresponding to the coding region of Wnt-5a (ctrl), the Wnt-5a 30-UTR region 1–66 (#1),
1–183 (#2) and 1–258 (#3) and cytoplasmic or nuclear lysates of HB2 cells (left panel). A control UV-crosslinking experiment (right panel) using the probe
corresponding to 1–258 (#3) without protein lysate added (3 w/o prot), with nuclear lysates from HB2 cells (3) or as a mutated probe with nuclear lysates from
HB2 cells (D3; see Materials and Methods). The UV-crosslinking data to the left were performed using
32P-labelled probes while the experiment with the mutated
probe (right panel) were performed using digoxigenin labelled probe. (B) REMSAs of probes corresponding to the coding region of Wnt-5a (ctrl), the Wnt-5a
30-UTR region 1–66 (#1), 1–183 (#2) and 1–258 (#3) and cytoplasmic or nuclear lysates of HB2 cells. Arrows indicate the proposed HuR complex and
* background. (C) Supershift experiments was performed using a HuR specific antibody 1:10 (left), a control antibody (IgG; right) or adding only probe #3
without protein lysates (3 w/o prot; right). Lower arrow indicates the proposed HuR complex, the upper arrow point to the supershift and the * indicate a
background band. A cold probe, C, corresponding to 1–258 (#3) was used in 10· excess as described in Materials and Methods. (D) Cytoplasmic lysates from
HB2 cells were mixed with the probe corresponding to 1–258 (probe 3), UV-crosslinked and control antibodies (IgG) or anti-HuR was used for
immunoprecipitation.
3994 Nucleic Acids Research, 2006, Vol. 34, No. 14(Figure 2C), most likely explains why we did not see a
reduced level of translated L2 in this set of experiments.
Endogenous Wnt-5a protein levels in breast epithelial
cell lines reflect Luc-30-UTR levels
To ensure that not only protein levels (Figure 5B, upper
panel) but also HuR localization (Figure 5A) were com-
parable, we performed immunohistochemistry with the HuR
speciﬁc antibody. As shown in Figure 5A, HuR was primarily
detected in the nuclei, with some cytoplasmic detection in all
three cell lines tested; the non-cancerous HB2 cell line and
the breast cancer cell lines MCF-7 and T47D. However,
since these different human breast epithelial cell lines express
varying protein levels of endogenous Wnt-5a (Figure 5B,
lower panel), we wanted to analyse whether these expression
levels reﬂected repression by HuR. Repression of the expres-
sion of transfected Luciferase-30-UTR reporters should in
theory reﬂect the ability and degree to which HuR could
repress endogenous Wnt-5a levels in the respective cell lines.
Figure 4. (A) In vivo effects of HuR or mutated HuR (M1 HuR) over-expression on (L, L1, L2 and L3) transfected HB2 human mammary epithelial cells (36 h)
cotransfected with Renilla as measured by Luciferase activity. Error bars indicate SEM (n ¼ 12). Statistical analyses were performed using Students paired t-test
(**P < 0.01; * P < 0.05). (B) Transfections in (A) were treated with Actinomycin D for 3 h and subjected to northern blot with Luciferase and Renilla specific
probes. The right panel is a histogram (mean ± SD) representing the ratio between OD Luciferase/OD Renilla. (C) In vitro transcription rate of Luciferase
vectors (L, L1, L2 and L3) performed using Rabbit reticulocyte lysate and [
32P]UTP (see Materials and Methods). Transcribed mRNAs were TCA-precipitated
and incorporated radioactivity was measured. Amount of UTP in each probe was corrected for. Error bars indicate SEM (n ¼ 10). (D) In vitro translation
experiments using the Luciferase vectors (L, L1, L2 and L3) with the Transcend  Non-radioactive translation detection systems (see Materials and Methods)
using Rabbit reticulocyte lysates only (upper panel) or pre-programmed with HuR (lower panel). The increased L2 construct transcription rate (C) should be
compared with its translation rate (D).
Nucleic Acids Research, 2006, Vol. 34, No. 14 3995Distinct from the variation in Wnt-5a protein expression
between the cell lines, differences in expression are also
evident following passaging and differ with the degree of
conﬂuency (45). Therefore in order to accurately represent
genuine change in degree of HuR-mediated repression
between the cell lines tested, we ensured that cell lysates
were consistently prepared from cells at similar stage of
conﬂuency. Transfection with the Luciferase-30-UTR cons-
tructs indicated that repression of the Wnt-5a 30-UTR
reﬂected the endogenous levels of Wnt-5a expression in the
respective cell lines. The construct carrying the potential
HuR-binding site (L2) was most signiﬁcantly affected indi-
cating that increased repression of translation was evident
where HuR had the ability to bind the 30-UTR (Figure 5C).
It is important to note that the modest differences obtained
are probably explained by the difﬁculty in comparing totally
different cell lines and the intrinsic variation of Wnt-5a,
which we attempted to control for. Also, the fact that L3 is
less affected than L1 in this experimental set up probably
lies in the nature of the experiment as the two breast
cancer cell lines used differ considerably in many aspects,
including protein expression pattern. Nevertheless, taking
these factors into account we can conclude that the reduction
in the Luciferase expression seen in the experiment can be
adequately explained by increased HuR-binding and may
thus be indicative of the endogenous control of Wnt-5a
translation.
Wnt-5a translation is further suppressed during
hypoxia
Hypoxia occurs in solid tumours where circulation is compro-
mised because of structurally disorganized blood vessels (46).
During hypoxia, active HuR has been shown to translocate to
the cytoplasm and protein expression of HuR was increased
(26,32). To investigate in detail the effect of HuR on
Wnt-5a translation under hypoxic conditions, we transfected
HB2 cells with the Luciferase-30-UTR constructs and placed
one dish in a normoxic chamber and one in a hypoxic
chamber for 24 h. Indeed, the translation efﬁciency of the
constructs carrying HuR-binding sites were signiﬁcantly
(P < 0.01) suppressed under hypoxic as compared to
normoxic conditions (Figure 6A), probably resembling the
situation of increased HuR activity in invasive breast cancer
as previously reported (35,36). A discrete increase in HuR
levels was detected in hypoxic cells just as previously
reported (32) (Figure 6B). Finally, the endogenous Wnt-5a
mRNA and protein levels were analysed after culturing
HB2 cells for 24 h under hypoxic, as compared to normoxic,
conditions. The Wnt-5a mRNA levels remained stable during
hypoxia and did not decrease as judged by semi-quantitative
RT–PCR (Figure 6C). If anything we observed a slight
increase in endogenous Wnt-5a mRNA under hypoxic condi-
tions. In the same samples, however, we found a consistent
decrease in endogenous Wnt-5a protein expression under
hypoxic conditions (P < 0.05; Figure 6D). The same experi-
ments were repeated in MCF-7 cells and similar results were
obtained (data not shown).
DISCUSSION
The importance of Wnt-5a signalling in metastasis has been a
matter of debate since conﬂicting results concerning the
expression levels of Wnt-5a in invasive tumours emerged in
the literature (9,12,18–24). One of the major reasons for this
is that most early studies concerning the role for Wnt-5a in
cancer, examined Wnt-5a mRNA and not protein levels.
We have previously shown that expression of the tumour
suppressor, Wnt-5a, is lost or severely down-regulated in
invasive human breast cancer, and hence is a predictor of
longer disease-free survival (12,13). The lack of expression
was not caused by a transcriptional defect since high
amounts of Wnt-5a mRNA was detected in otherwise protein
negative tumours (13).
Wnt proteins have not generally been viewed as proteins
that are regulated through a post-transcriptional mechanism.
However, there are two reports concerning 30-UTR
post-transcriptional regulation of non-mammalian Xwnt-8,
Awnt-5A, Awnt-5B and Awnt-1 (47,48). These studies
Figure 5. (A) Immunofluorescence analysis of HuR localization in HB2,
MCF-7 and T47D cell lines. (B) Western blot of endogenous HuR (upper
panel) and Wnt-5a expression (lower panel) in HB2 non-cancerous mam-
mary epithelial cells compared to two cancer cell lines MCF-7 and T47D.
(C) Transfection experiments (24 h) with the human breast cancer cell lines
MCF-7 and T47D. Luciferase assay of transfected (L, L1, L2 and L3) cell
lines cotransfected with Renilla. Relative Luciferase Units (RLU)/Renilla
Luciferase Units (transfection efficiency control) indicate decreased expres-
sion (P < 0.05) of Luciferase reporters containing the most conserved AREs
(1–183 bp; L2) of the Wnt-5a 30-UTR in a cell line expressing low levels of
endogenous Wnt-5a (T47D) compared to a cell line expressing high levels of
endogenous Wnt-5a (MCF-7). Endogenous Wnt-5a expression varies
between different cell lines with replating and confluency and yet unknown
mediators probably explain why L3 is less affected than L2 in this model.
Error bars indicate SEM (n ¼ 10). Statistical analyses were performed using
Student’s paired t-test (*P < 0.05).
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stabilization as well as mRNA localization. In the present
study we present the novel ﬁnding that the human
Wnt-5a mRNA contains evolutionarily conserved sequence
elements (AREs) in its 30-UTR that are implicated in
post-transcriptional regulation. Moreover, a recent global
analysis of HuR regulated genes identiﬁed Wnt-5b as a
potential target (49). Wnt-5a and Wnt-5b are almost identical
in their coding region, but their 30-UTR are different. The
30-UTR of Wnt-5b is neither conserved, nor does it contain
a repetitive AU-rich stretch, as in the 30-UTR of Wnt-5a.
Here we show for the ﬁrst time that Wnt-5a is regulated at
the post-transcriptional level. The regulation is caused by a
HuR-mediated suppression of translation. We further show
that the low Wnt-5a protein expression level in breast tum-
ours is not caused by HuR-mediated destabilization of the
Wnt-5a mRNA. Rather, and in line with our previous ﬁndings
(13), the mRNA levels in otherwise Wnt-5a protein negative
breast cancers have a high or normal level of Wnt-5a mRNA.
Several RNA-binding proteins that are speciﬁc for AREs
have been characterized (26,27). The Elav-like protein HuR
has been previously reported to primarily stabilize mRNAs
(31). We show that four proteins bind to the most conserved
sequence elements of the human Wnt-5a 30-UTR; 20, 36
(corresponding to HuR), 45 and 98 kDa. The data presented
in this study strongly indicate that HuR binds to the 30-UTR
of Wnt-5a and, importantly, it binds AREs to suppress trans-
lation. The fact that Hu proteins can bind mRNAs to affect
translation has been observed previously (29,50), although
with distinct differences (i.e. increased translation or inhibi-
tion of IRES-dependent translation). An important similarity
to our study however, is that the Hu proteins were also sug-
gested to bind AREs of class III in these studies (29,50,51).
Furthermore, our ﬁnding is supported by a recent study
where HuR was reported as a negative translational regulator
in mammalian cells acting in synergy with the translational
repressor TIA-1 (30). TIA-1 and TIAR belong to the same
family of proteins and are both translational repressors of
 45 kDa (25). We believe that HuR is an essential protein
for regulating translational suppression, most likely in
cooperation with at least one more protein as has previously
been suggested (30,52). Invasive human breast cancers have
high levels of HuR in the cytoplasm (HuRc) (36). Invasive
human breast cancers also have low Wnt-5a expression levels
(12,13). Clinical support for the concept that HuR acts in
synergy with at least one more protein comes from the ﬁnding
that an increased level of HuRc in invasive breast cancer
only corresponds to tumour grade, whereas loss of Wnt-5a
expression correlates to survival.
It has been shown that HuR affects mRNA and translation
primarily in the cytoplasm, as exempliﬁed by the increased
Cox-2 mRNA and protein expression levels found in HuRc
positive breast cancers (35). It is therefore possible that the
decreased protein expression level of Wnt-5a in human
invasive breast cancer also is a direct consequence of HuR
expression and cellular distribution. Hypoxia that exists in
many solid tumours, leads to an increased expression of
HuR but also leads to translocation of active HuR to the cyto-
plasm (32). We have taken advantage of this ﬁnding to mimic
the HuR phenotype in invasive breast cancers and conse-
quently found a decreased Wnt-5a translation rate during
hypoxic conditions as shown using both Luciferase reporter
vectors and endogenous Wnt-5a protein. Whether hypoxia
affects other RNA-binding proteins, in addition to HuR, is
not known. Interestingly, TIAR has been reported to be
upregulated in neurons after ischemic brain injury (53).
Figure 6. (A) The effects of hypoxia on Wnt-5a translation. The reporters
containing the HuR-binding site is significantly suppressed under hypo-
xia compared to normoxia (24 h; P < 0.01 t-test). Error bars indicate SEM
(n ¼ 6). (B) A discrete increase in HuR protein expression level (n ¼ 7) was
observed as described previously (32). The increase varied between different
experiments and all data points are included in the statistical evaluation.
(C) Endogenous Wnt-5a (upper panel) and actin (lower panel) mRNA levels
in HB2 cells grown under hypoxic compared to normoxic conditions. (D)A
significant decrease in Wnt-5a protein level was detected in cells cultured
under hypoxic conditions (P < 0.05 t-test; n ¼ 6). Statistical analyses were
performed using Student’s paired t-test (**P < 0.01; * P < 0.05).
Nucleic Acids Research, 2006, Vol. 34, No. 14 3997A growing number of genes that are affected by HuR, or
related proteins, are reported. Many of them are genes
associated with inﬂammation, but also with tumourigenesis
and metastasis, such as c-myc, p53, VEGF, Cox-2, the cyclins
(26) and now Wnt-5a. Whether the altered activity of HuR is
caused by differentiation, hypoxia, nutrient-starvation or by
other unrelated factors in the primary tumours will need to
be further investigated. However, the fact that the effects of
one group of proteins can affect numerous target proteins is
intriguing both in the aspect of inﬂammation and as shown
here, also in that of cancer. Efforts should be made to under-
stand these mechanisms better with the goal to design novel
cancer therapies based on post-transcriptional regulatory
proteins.
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